Skip to main content

Daniel Snyder, PhD Joins Propel Health Medical Affairs

Snyder’s Expertise Will Guide Pharma and Biotech Clients to Launch Success

Propel Health Medical Affairs (PHMA), a full-service medical communications agency within the Propel Health network of companies, today welcomes Daniel Snyder, PhD as Executive Vice President, Advisory Services.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251120435109/en/

Daniel Snyder, PhD, Executive Vice President

Daniel Snyder, PhD, Executive Vice President

In this role, Daniel will work directly with pharmaceutical and biotechnology clients to build and execute Medical Affairs launch plans, ensuring clients are fully prepared for every stage of product introduction. With more than two decades of client-facing launch leadership, Daniel is renowned for his hands-on approach, helping teams achieve launch excellence while navigating the complex realities of today’s markets.

Daniel’s expertise touches all core areas of pre-launch readiness: integrated evidence planning, scientific strategy development, experience in 11 therapeutic areas, and market preparation. He has built Medical Affairs, HEOR, and RWE organizations from the ground up, and he has achieved Medical Excellence in other organizations. Having led and supported the successful launch of multiple breakthrough products, Daniel brings deep, practical knowledge in aligning cross-functional teams, building strong KOL partnerships, supporting payer and provider engagement, and ensuring that scientific communication is clear, compliant, and impactful.

Clients will benefit from Daniel’s trusted counsel as he works side-by-side to shape their launch plans, support advisory boards, develop omnichannel engagement, optimize HEOR and RWE strategy, and deliver end-to-end operational excellence for every pre-launch milestone. Daniel is known for translating evidence and strategy into executable solutions that maximize resources and drive measurable results for both companies and patients.

“I am delighted to have Daniel join us not just for his expertise, but for his wisdom, honesty, and unwavering dedication to helping our partners succeed,” said Jeff Keller, President of Propel Health Medical Affairs. “He’s a patient listener, a thoughtful advisor, creative and solution-oriented, and a genuinely kind person. Daniel’s integrity and commitment shine through in every project, and our clients will immediately feel the difference in working with him.”

About Propel Health Medical Affairs

Propel Health Medical Affairs brings together strategy, scientific content, and innovation to transform clinical behaviors. The team delivers services across a brand’s life cycle, including medical strategy, publication planning, congress and advisory board management, medical education, scientific communications, and stakeholder engagement. With deep therapeutic knowledge and a commitment to scientific rigor, Propel Health Medical Affairs enables clients to translate complex data into clear, credible insights that advance patient care and inform confident decision-making. Learn more at MedicalAffairs.PropelHealth.com.

Propel Health Medical Affairs is part of the Propel Health network, which includes: Propel Health Engagements, the industry-leading provider of speaker bureau solutions; Propel Health Communications, a full-service promotional and medical communications agency that builds strategic solutions that propel brands—and health—forward; and Propel Health Patient Experience, a trusted partner of the life sciences industry for authentic engagement with patients, caregivers, and advocacy groups to fuel brand success.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.28
+5.59 (2.53%)
AAPL  275.92
+4.43 (1.63%)
AMD  215.05
+11.27 (5.53%)
BAC  51.93
+0.37 (0.72%)
GOOG  318.47
+18.82 (6.28%)
META  613.05
+18.80 (3.16%)
MSFT  474.00
+1.88 (0.40%)
NVDA  182.55
+3.67 (2.05%)
ORCL  200.28
+1.52 (0.76%)
TSLA  417.78
+26.69 (6.82%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.